IQVIA Pharma Deals Half-Year Review of 2019

White Paper

September 6, 2019
IQVIA Pharma Deals Half Year Review of 2019

The IQVIA Pharma Deals Half-Year Review of 2019 provides an insightful overview of deal activity in the first half of 2019, as well as an outlook for the remainder of 2019. Key information provided includes the following:

  • Top M&A and partnership deals of H1 2019
  • Deal activity rankings of the top pharmaceutical companies
  • Therapeutic area and development phase deal activity
  • Deal value analysis of M&A, licensing and R&D deals

 

Key Highlights

  • Big-ticket M&A returned to the biopharmaceutical sector, driving an upturn in M&A deal values
  • Bucking the downward trend seen in previous years, the number of collaborative R&D agreements was up in H1 2019 with deals becoming increasingly broad
Get more details about IQVIA Pharma Deals today.